Jin Medical International-AZJYL
13F holders, Q1 2025 (March 31)17holders +7
9new positions
2sold out
1famous investor
$0.74avg. 13F price*
At the end of Q1 2025, 17 institutions reported holding Jin Medical International-A (ZJYL) in their 13F filings, up 7 from Q4 2024. 9 opened new positions and 2 sold out. The largest holders were UBS Group AG ($127K), Jane Street Group, LLC ($118K) and Millennium Management ($102K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Jin Medical International-A
- CUSIP
- G5140V112
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $408K |
| Exits | 2 | $1.1M |
All 13F filers, Q4 2024 → Q1 2025: 561,510 shares bought and 1,480,837 shares sold, net −919,327 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| UBS Group AG | 0.00% | Reduce -10.7% | 170,548 | $127K |
| Jane Street Group, LLC | 0.00% | New | 158,763 | $118K |
| Millennium Management | 0.00% | New | 136,575 | $102K |
| Goldman Sachs Group Inc. | 0.00% | New | 131,091 | $97K |
| Invesco Ltd. | 0.00% | Add +2.3% | 130,062 | $97K |
| Geode Capital Management, LLC | 0.00% | No change | 106,540 | $79K |
| Susquehanna International Group, LLP | 0.00% | New | 62,351 | $46K |
| XTX Topco Ltd | 0.00% | New | 22,959 | $17K |
| Two Sigma Investments, LP | 0.00% | Reduce -36.1% | 20,939 | $16K |
| Two Sigma Securities, LLC | 0.00% | New | 19,496 | $14K |
| Osaic Holdings, Inc. | 0.00% | Add +39.1% | 19,450 | $14K |
| WINTON GROUP Ltd | 0.00% | New | 15,080 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +91.9% | 7,639 | $6K |
| JPMorgan Chase & Co. | 0.00% | New | 2,480 | $2K |
| Morgan Stanley | 0.00% | Add +174.0% | 929 | $691 |
| Bell Investment Advisors, Inc | 0.00% | No change | 152 | $113 |
| Bank of America Corp. | 0.00% | New | 35 | $26 |
"% of holder's portfolio" is ZJYL's weight in each manager's 13F, not the share of Jin Medical International-A the manager owns.